NCT07425509

Brief Summary

This single-center, randomized, double-blind, two-treatment crossover clinical study evaluated the safety and efficacy of a stannous fluoride-containing dentifrice compared with a sodium fluoride control dentifrice for the control of intrinsic oral malodor. Adult subjects brushed twice daily with each product during separate treatment periods following standardized wash-out periods. Oral malodor was assessed using trained organoleptic judges applying a validated Odor Intensity (OI) scale at baseline and multiple post-treatment time points.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

2 months

First QC Date

February 16, 2026

Last Update Submit

February 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Odor Intensity Score (OI

    Baseline to 12-hour overnight assessment after 7 days of product use

Secondary Outcomes (1)

  • Change in Odor Intensity Score at Day 1

    Mean change in Odor Intensity Scores from baseline to Day 1 overnight assessment.

Other Outcomes (1)

  • Daytime Odor Intensity Scores

    4 and 8 hours post-brushing on Day 1 and Day

Study Arms (2)

Sodium Fluoride Control Dentifrice

OTHER

Dentifrice containing sodium fluoride, serving as the control comparator.

Drug: Sodium Fluoride Dentifrice

Stannous Fluoride Toothpaste

EXPERIMENTAL

Dentifrice containing stannous fluoride evaluated for malodor reduction compared to sodium fluoride control.

Drug: Stannous Fluoride Toothpaste (SnF)

Interventions

Comparator toothpaste (0.243% NaF)

Sodium Fluoride Control Dentifrice

Test toothpaste (0.454% SnF)

Stannous Fluoride Toothpaste

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥18 years of age in good general health
  • Baseline odor intensity score ≥2 after approximately 12 hours of oral hygiene abstention
  • Intra-oral source of oral malodor
  • At least 18 natural teeth
  • Willing to comply with oral hygiene, dietary, and behavioral restrictions
  • Able to provide informed consent

You may not qualify if:

  • Allergy to oral hygiene products
  • Pregnant or nursing
  • Serious medical conditions affecting oral malodor
  • Recent antibiotic or anti-inflammatory medication use
  • Smoker or user of smokeless tobacco
  • Advanced periodontal disease, frank caries, or significant oral pathology
  • Participation in another oral care study within 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salus Research, Inc.

Fort Wayne, Indiana, 46825, United States

Location

MeSH Terms

Conditions

Halitosis

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Annahita Ghassemi, PhD

    Church & Dwight, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 23, 2026

Study Start

September 9, 2024

Primary Completion

November 4, 2024

Study Completion

November 4, 2024

Last Updated

February 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

The sponsor does not plan to share individual participant data. Summary results will be provided as required, but no de-identified datasets will be made publicly available.

Locations